Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease

Abstract excerpt

INTRODUCTION: Parkinson's disease (PD) is a complex and phenotypically heterogeneous neurodegenerative disease, for which the diagnosis is mainly based on clinical parameters (even if neuroimaging plays a role in diagnostic assessment); as a consequence, misdiagnosis is common, especially in early stages. Thus, there is an urgent need of having available biomarkers in order to achieve an early and accurate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Neurodegenerative Diseases
• Share to Neurological disorders and treatments
• Share to Parkinson's Disease Mechanisms and Treatments